Evidence map›Paper›PMID 32110551›Full record

ReviewResearch and reports in urology2020

Review of Testicular Tumor: Diagnostic Approach and Management Outcome in Africa.

Ayun Cassell, Mohamed Jalloh, Medina Ndoye, Bashir Yunusa, Mouhamadou Mbodji, Abdourahmane Diallo, Omar Gaye, Issa Labou, Lamine Niang, Serigne Gueye

Abstract readReview
In one paragraph

Review in Research and reports in urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Testicular Cancer in Saudi Arabia Between 2004 and 2017.Research and reports in urology · 2023
    Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ayun CassellDepartment of Urology and Andrology, Hopital General de Grand Yoff, Dakar, Senegal.ORCID 0000-0002-7977-6682
Mohamed JallohDepartment of Urology and Andrology, Hopital General de Grand Yoff, Dakar, Senegal.
Medina NdoyeDepartment of Urology and Andrology, Hopital General de Grand Yoff, Dakar, Senegal.ORCID 0000-0002-2864-3898
Bashir YunusaDepartment of Surgery, Liberia College of Physicians and Surgeons, Monrovia, Liberia.
Mouhamadou MbodjiDepartment of Urology and Andrology, Hopital General de Grand Yoff, Dakar, Senegal.
Abdourahmane DialloDepartment of Urology and Andrology, Hopital General de Grand Yoff, Dakar, Senegal.
Omar GayeDepartment of Urology and Andrology, Hopital General de Grand Yoff, Dakar, Senegal.ORCID 0000-0001-8873-9560
Issa LabouDepartment of Urology and Andrology, Hopital General de Grand Yoff, Dakar, Senegal.
Lamine NiangDepartment of Urology and Andrology, Hopital General de Grand Yoff, Dakar, Senegal.
Serigne GueyeDepartment of Urology and Andrology, Hopital General de Grand Yoff, Dakar, Senegal.ORCID 0000-0001-7805-7574

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Testicular cancer is a common malignancy in young males with higher incidence in developed nations but with the lowest incidence in Africa (0.3-0.6/100 000). Ironically, the global testicular cancer mortality rate has shown a reverse trend to its incidence with higher rates in low- and middle-income countries (0.5 per 100 000) than in high-income countries. Data from GLOBOCAN 2008 have shown relatively high mortality rates in sub-Saharan countries like Mali, Ethiopia, Niger and Malawi. The prognosis of testicular tumor is good with remarkable chemosensitivity to cisplatin-based regimen. Early diagnosis, careful staging and a multidisciplinary management approach is crucial to achieve this optimal result. These results are achievable in the sub-Saharan region if the relevant resources are appropriated for cancer care and clinical guidelines are formulated in a regional context.

Indexed as

germ cellorchidectomytesticular cancer

Identifiers

PMID32110551
PMCPMC7035899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.